Literature DB >> 25392844

Complications after percutaneous ablation of liver tumors: a systematic review.

Eylon Lahat1, Rony Eshkenazy1, Alex Zendel1, Barak Bar Zakai1, Mayan Maor1, Yael Dreznik1, Arie Ariche1.   

Abstract

BACKGROUND: Although ablation therapy has been accepted as a promising and safe technique for treatment of unrespectable hepatic tumors, investigation of its complications has been limited. A physician who performs ablation treatment of hepatic malignancies should be aware of the broad spectrum of complications. Proper management is possible only if the physician Performing ablation understands the broad spectrum of complications encountered after ablation.
OBJECTIVES: TO SYSTEMATICALLY REVIEW THE COMPLICATIONS AFTER DIFFERENT ABLATION MODALITIES: Radiofrequency ablation (RFA), microwave ablation (MWA) and Nano knife for the treatment of liver tumors and analyze possible risk factors that precipitate these complications. SEARCH
METHODS: WE PERFORMED ELECTRONIC SEARCHES IN THE FOLLOWING DATABASES: MEDLINE, EMBASE and COCHARNE. Current trials were identified through the Internet (from January 1, 2000 to January 1, 2014). We included only studies who specific mentioned complications after liver ablation therapy (RFA/MWA/Nano knife). MAIN
RESULTS: A total of 2,588 publications were identified, after detailed examination only 32 publications were included in the review. The included studies involved 15,744 participants. According to the type of technique, 13,044 and 2,700 patients were included for RFA and MWA. Analysis showed a pooled mortality of 0.15% for RFA, and 0.23% for MWA.
CONCLUSIONS: This systematic review gathers information from controlled clinical trials and observational studies which are vulnerable to different types of bias, never the less RFA and MWA can be considered safe techniques for the treatment of liver tumors.

Entities:  

Keywords:  Liver tumors; liver metastases; percutaneous ablation; systematic review

Year:  2014        PMID: 25392844      PMCID: PMC4207846          DOI: 10.3978/j.issn.2304-3881.2014.09.07

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  52 in total

Review 1.  Loco-regional treatment of hepatocellular carcinoma.

Authors:  Riccardo Lencioni
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

2.  Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors: 3-year experience with 336 patients at a single center.

Authors:  Antonio Giorgio; Luciano Tarantino; Giorgio de Stefano; Carmine Coppola; Giovanna Ferraioli
Journal:  AJR Am J Roentgenol       Date:  2005-01       Impact factor: 3.959

3.  Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.

Authors:  Chandrajit P Raut; Francesco Izzo; Paolo Marra; Lee M Ellis; Jean-Nicolas Vauthey; Francesco Cremona; Paolo Vallone; Angelo Mastro; Bruno D Fornage; Steven A Curley
Journal:  Ann Surg Oncol       Date:  2005-06-20       Impact factor: 5.344

Review 4.  The role of microwave ablation in the management of hepatic colorectal metastases.

Authors:  C Jones; S A Badger; G Ellis
Journal:  Surgeon       Date:  2010-08-21       Impact factor: 2.392

5.  Biloma formation after radiofrequency ablation of hepatocellular carcinoma: incidence, imaging features, and clinical significance.

Authors:  Il Soo Chang; Hyunchul Rhim; Seong Hyun Kim; Young-sun Kim; Dongil Choi; Yulri Park; Hyo Keun Lim
Journal:  AJR Am J Roentgenol       Date:  2010-11       Impact factor: 3.959

6.  Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings.

Authors:  Hyunchul Rhim; Kwon-Ha Yoon; Jeong Min Lee; Yoonkoo Cho; June-Sik Cho; Seung Hoon Kim; Won-Jae Lee; Hyo Keun Lim; Gyoung-Jin Nam; Sang-Suk Han; Yun Hwan Kim; Cheol Min Park; Pyo Nyun Kim; Jae-Young Byun
Journal:  Radiographics       Date:  2003 Jan-Feb       Impact factor: 5.333

Review 7.  Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: current status and future perspectives.

Authors:  Andrew X Zhu
Journal:  Semin Oncol       Date:  2012-08       Impact factor: 4.929

8.  Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation.

Authors:  Andrea Ruzzenente; Giovanni De Manzoni; Matteo Molfetta; Silvia Pachera; Bruno Genco; Matteo Donataccio; Alfredo Guglielmi
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

9.  Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients.

Authors:  Hiroshi Kasugai; Yukio Osaki; Hiroko Oka; Masatoshi Kudo; Toshihito Seki
Journal:  Oncology       Date:  2007-12-13       Impact factor: 2.935

10.  Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients--mathematic model, overlapping mode, and electrode placement process.

Authors:  Min-Hua Chen; Wei Yang; Kun Yan; Ming-Wu Zou; Luigi Solbiati; Ji-Bin Liu; Ying Dai
Journal:  Radiology       Date:  2004-05-27       Impact factor: 11.105

View more
  31 in total

Review 1.  Microwave ablation of hepatocellular carcinoma.

Authors:  Guido Poggi; Nevio Tosoratti; Benedetta Montagna; Chiara Picchi
Journal:  World J Hepatol       Date:  2015-11-08

Review 2.  Ablation techniques for primary and metastatic liver tumors.

Authors:  Michael J Ryan; Jonathon Willatt; Bill S Majdalany; Ania Z Kielar; Suzanne Chong; Julie A Ruma; Amit Pandya
Journal:  World J Hepatol       Date:  2016-01-28

3.  Percutaneous radiofrequency ablation of hepatocellular carcinoma in cirrhosis: analysis of complications in a single centre over 20 years.

Authors:  Antonio Giorgio; Maria G Merola; Luca Montesarchio; Francesca Merola; Pietro Gatti; Carmine Coppola; Valentina Giorgio; Giorgio Calisti
Journal:  Br J Radiol       Date:  2017-05-25       Impact factor: 3.039

Review 4.  Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy.

Authors:  Thomas J Byrne; Jorge Rakela
Journal:  World J Transplant       Date:  2016-06-24

5.  EUS dating with laser ablation against the caudate lobe or left liver tumors: a win-win proposition?

Authors:  Tian'an Jiang; Guo Tian; Haiwei Bao; Fen Chen; Zhuang Deng; Ju Li; Weilu Chai
Journal:  Cancer Biol Ther       Date:  2018-01-25       Impact factor: 4.742

6.  Fully laparoscopic thermo-ablation of liver malignancies with or without liver resection: tumor location is an independent local recurrence risk factor.

Authors:  Geoffrey Ledoux; Koceila Amroun; Rami Rhaiem; Audrey Cagniet; Arman Aghaei; Olivier Bouche; Christine Hoeffel; Daniele Sommacale; Tullio Piardi; Reza Kianmanesh
Journal:  Surg Endosc       Date:  2020-02-19       Impact factor: 4.584

Review 7.  New horizons in ablation therapy for hepatocellular carcinoma.

Authors:  Jacob Freedman; Henrik Nilsson; Eduard Jonas
Journal:  Hepat Oncol       Date:  2015-11-06

Review 8.  Septic Shock and Death after Microwave Ablation of Hepatocellular Carcinoma in a Liver Transplant Patient with a Bilioenteric Anastomosis.

Authors:  Raymond Melikian; Jeet Minocha
Journal:  Semin Intervent Radiol       Date:  2019-05-22       Impact factor: 1.513

9.  Percutaneous Microwave Ablation Under CT Guidance for Hepatocellular Carcinoma: a Single Institutional Experience.

Authors:  Claudio Pusceddu; Luca Melis; Nicola Ballicu; Barbara Sotgia; Marcovalerio Melis; Valeria Sanna; Giovanni Battista Meloni; Alberto Porcu; Alessandro Fancellu
Journal:  J Gastrointest Cancer       Date:  2018-09

Review 10.  Strategies for the delay of surgery in the management of resectable hepatobiliary malignancies during the COVID-19 pandemic.

Authors:  S Bennett; K Søreide; S Gholami; P Pessaux; C Teh; E Segelov; H Kennecke; H Prenen; S Myrehaug; D Callegaro; J Hallet
Journal:  Curr Oncol       Date:  2020-10-01       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.